Skip to main content
Premium Trial:

Request an Annual Quote

Lynx, Hybrigenics Partner For Obesity Gene Studies


HAYWARD, Calif.--Lynx Therapeutics and Hybrigenics of Paris are working together to discover expressed genes, protein interactions, and pathways in human obesity. Both companies intend to use the findings to create new diagnostics and treatments for this disease area.

Lynx will use its DNA cloning and analysis technologies to discover novel expressed genes in the formation and differentiation of human fat cells. Hybrigenics plans to expand these discoveries to identify the protein interactions and pathways involved in this process.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.